Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Swain

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Important Advances in Oncology|January 1, 1989
Treatment of patients with inflammatory breast cancerS M Swain, M E Lippman
Oncology (Williston Park, N.Y.)|October 18, 2000
Update on adjuvant chemotherapy for early breast cancerN J McCarthy, S M Swain
Seminars in Oncology|August 11, 2001
Adjuvant chemotherapy for breast cancer: an updateA R Tan, S M Swain
Seminars in Oncology|November 14, 2001
Novel agents: clinical trial designA R Tan, S M Swain
Important Advances in Oncology|January 1, 1993
Hormonal manipulation in the adjuvant treatment of breast cancerS F Honig, S M Swain
American Family Physician|August 1, 1991
Adjuvant therapy in early breast cancerS R Chittoor, S M Swain
Plant Physiology|September 1, 1996
Genetic Analysis of Gibberellin Signal TransductionS. M. Swain, N. E. Olszewski
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Tumor markers: should we or shouldn't we?N J McCarthy, S M Swain
American Journal of Clinical Oncology|August 1, 1988
Salvage treatment with intermediate-dose methotrexate and 5-fluorouracil in metastatic breast cancerS M Swain, S Steinberg, M Lippman
Current Oncology (Toronto, Ont.)|December 31, 2015
Does CDKN2A loss predict palbociclib benefit?J Gao, R P Adams, S M Swain
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Important Advances in Oncology|January 1, 1989
Treatment of patients with inflammatory breast cancerS M Swain, M E Lippman
Oncology (Williston Park, N.Y.)|October 18, 2000
Update on adjuvant chemotherapy for early breast cancerN J McCarthy, S M Swain
Seminars in Oncology|August 11, 2001
Adjuvant chemotherapy for breast cancer: an updateA R Tan, S M Swain
Seminars in Oncology|November 14, 2001
Novel agents: clinical trial designA R Tan, S M Swain
Important Advances in Oncology|January 1, 1993
Hormonal manipulation in the adjuvant treatment of breast cancerS F Honig, S M Swain
American Family Physician|August 1, 1991
Adjuvant therapy in early breast cancerS R Chittoor, S M Swain
Plant Physiology|September 1, 1996
Genetic Analysis of Gibberellin Signal TransductionS. M. Swain, N. E. Olszewski
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Tumor markers: should we or shouldn't we?N J McCarthy, S M Swain
American Journal of Clinical Oncology|August 1, 1988
Salvage treatment with intermediate-dose methotrexate and 5-fluorouracil in metastatic breast cancerS M Swain, S Steinberg, M Lippman
Current Oncology (Toronto, Ont.)|December 31, 2015
Does CDKN2A loss predict palbociclib benefit?J Gao, R P Adams, S M Swain
Pageof 8